INTRODUCTION
============

Accurate transfer of genetic information is critical for cellular maintenance and integrity, with each stage of gene expression requiring different levels of fidelity ([@gks1240-B1]). DNA replication is an extremely accurate process with an error rate of 1 in 10^8^ ([@gks1240-B2]), whereas messenger RNA transcription and translation are relatively less accurate with misincorporation rates of 10^−5^ and 10^−4^, respectively ([@gks1240-B3; @gks1240-B4; @gks1240-B5]). Fidelity in translation is dependent on several steps including synthesis of cognate aminoacyl transfer RNAs (aa-tRNAs) by aminoacyl tRNA synthetases (aaRSs), binding of aa-tRNAs by elongation factor Tu (EF-Tu), and accurate selection of aa-tRNAs by the ribosome ([@gks1240-B6; @gks1240-B7; @gks1240-B8]). The aaRS family is composed of 23 distinct enzymes, each of which is responsible for ligating a single amino acid to a subset of tRNAs with specific anticodon sequences. Aminoacylation of tRNA by aaRSs is a two-step reaction, consisting of adenosine triphosphate (ATP)-dependent amino acid activation followed by ligation of amino acid to the 3′-end of tRNA forming an aminoacyl ester bond ([@gks1240-B9]). During the activation step, approximately half of the aaRSs display a level of specificity of 3000:1 or greater for cognate versus non-cognate amino acids, which is similar to overall error rates typically observed during protein synthesis ([@gks1240-B10]). For the other aaRSs, the existence of closely related near-cognate substrates precludes a high level of cognate amino acid discrimination, and these enzymes depend on an additional proofreading function called 'editing' for quality control ([@gks1240-B11]). Editing is categorized as pre- or post-transfer depending on whether products of the first or second step of the aminoacylation reaction are hydrolyzed, respectively ([@gks1240-B6],[@gks1240-B12],[@gks1240-B13]). AaRS editing contributes to quality control as part of a 'double sieve' mechanism ([@gks1240-B14],[@gks1240-B15]). The first sieve is the synthetic active site of the aaRS, which determines the specificity for cognate substrate. The second sieve is an editing or proofreading activity to clear either near-cognate amino acids or mischarged tRNAs.

The aaRSs are an essential family of enzymes, but their corresponding editing activities are not required for cell viability under standard laboratory growth conditions \[reviewed in ([@gks1240-B16])\]. Although not lethal, defects in aaRS editing lead to mistranslation that results in stress responses because of the accumulation of misfolded proteins in eukaryotic cells, and increased susceptibility to some antibiotics and induction of the SOS mechanism in bacteria ([@gks1240-B17; @gks1240-B18; @gks1240-B19; @gks1240-B20; @gks1240-B21; @gks1240-B22]). Specific mechanisms actively reduce aaRS quality control and elevate misacylation under certain growth conditions, which can be beneficial for cell survival ([@gks1240-B23; @gks1240-B24; @gks1240-B25; @gks1240-B26]). The finding that aaRS-dependent mistranslation can be detrimental or advantageous depending on growth conditions suggests that accuracy may be a variable, selectable, trait rather than an absolute requirement for viable translation ([@gks1240-B27],[@gks1240-B28]). To further investigate the evolution of aaRS quality control mechanisms and their role in regulating the accuracy of translation, we examined the discrimination of near-cognate tyrosine by phenylalanyl-tRNA synthetase (PheRS) from *Mycoplasma mobile.* Previous studies have shown that PheRS proofreading mechanisms display considerable structural and functional diversity between different organisms and cellular compartments, suggesting they have adapted to divergent cellular requirements for translation quality control ([@gks1240-B27]). *M. mobile* provides an ideal model system to investigate the evolution of PheRS quality control, as the extensive mistranslation observed in the proteome of this organism was recently proposed to be directly linked to the absence of canonical editing domains in several aaRSs, including PheRS ([@gks1240-B28]). Here, we show that *M. mobile* PheRS (*Mm*PheRS) has lost post-transfer editing activity against misaminoacylated tRNA, and has acquired an alternative, albeit less efficient, quality control pathway dependent on kinetic proofreading. Sequence alignment-based single amino acid replacements in *Mm*PheRS substantially increased proofreading activity *in vivo* and *in vitro*, suggesting that the mechanistic changes observed in the enzyme reflect divergent selection pressures on the translation quality control machinery during evolution. The possible advantages to proteome integrity of regulating translation accuracy via aaRS quality control mechanisms are discussed.

MATERIALS AND METHODS
=====================

General methods
---------------

Site-directed mutagenesis was performed by polymerase chain reaction using primers obtained from Sigma. Aminoacylation, ATP consumption, deacylation and steady state kinetic assays were performed as described previously ([@gks1240-B17],[@gks1240-B29]).

Preparation of *Mm*PheRS
------------------------

GeneIDs for *M. mobile pheS* encoding the α subunit and *pheT* encoding the β subunit are MMOB3170 and MMOB5160, respectively. *M. mobile* gene sequences were codon optimized for expression in *Escherichiacoli*; specifically, TGA codons were substituted with TGG codons, and the modified operon was synthesized (GenScript). The intergenic sequence between *pheS* and *pheT* genes was replaced with the sequence from that in *E. coli* to ensure efficient transcription and translation of the two subunits in *E. coli*. The *Mm*PheRS-encoding genes were subcloned into pQE31 vector (Qiagen) at SacI and HindIII restriction sites. The resulting plasmid pQE31-His~6~-*Mm*PheRS was used to transform *E. coli* BL21(DE3)pLysS cells. Cells were grown to an optical density at 600 nM (OD~600~) of 0.4 at 37°C, 250 r.p.m., and then grown until an OD~600~ of 0.7 at 22°C, 250 r.p.m. Isopropyl-β-D-thiogalactoside (IPTG) was then added to a final concentration of 0.5 mM, and cells were grown overnight at 22°C, 250 r.p.m. Cells were harvested; the pellet was resuspended in a buffer containing 25 mM Tris--HCl (pH 8.0), 300 mM NaCl, 10% glycerol and 5 mM imidazole, and flash frozen using liquid N~2~ before storage at −80°C. The frozen cells were thawed at 37°C for 10 min and sonicated, and supernatant was collected after centrifugation at 50 000 r.p.m. for 1 h. The supernatant was applied to a pre-equilibrated 3 ml TALON® resin metal affinity column (Clontech) followed by washing, and the protein was eluted with Tris--HCl (pH 8.0), 300 mM NaCl, 250 mM imidazole and 10% glycerol. Fractions containing *Mm*PheRS were checked for electrophoretic purity by sodium dodecyl sulphate--polyacrylamide gel electrophoresis, pooled and dialyzed overnight at 4°C into buffer containing 10 mM Tris--HCl (pH 8.0), 200 mM NaCl, 5 mM NaH~2~PO~4~ and 10% glycerol, after which the protein was aliquoted and stored at −20°C in the same buffer with 50% glycerol.

Cloning and *in vitro* transcription of *M. mobile* tRNA^Phe^
-------------------------------------------------------------

The gene for *M. mobile* tRNA^Phe^~GAA~ (GeneID: MMOB9150) was synthesized using synthetic DNA oligomers according to standard procedures ([@gks1240-B30]) and cloned into pUC19 vector using BamHI and HindIII restriction sites to yield pUC19-*Mm*tRNA^Phe^. This plasmid (200 µg) was digested with BstNI to generate 3′ CCA and used as a template for run-off transcription using T7 RNA polymerase. The tRNA transcript was purified on denaturing 12% polyacrylamide gel and extracted by electrodialysis in 90 mM Tris-borate/2 mM ethylenediaminetetraacetic acid (EDTA) (pH 8.0). The tRNA was phenol and chloroform extracted, ethanol precipitated and resuspended in diethylpyrocarbonate (DEPC)-treated ddH~2~O. Refolding was carried out by heating the tRNA at 70°C for 2 min, followed by addition of MgCl~2~ to a concentration of 2 mM and subsequent slow cooling to room temperature.

Tyr-tRNA^Phe^ preparation and hydrolysis assays
-----------------------------------------------

Wild-type *Mm*PheRS (1 µM) was used to aminoacylate 5 µM tRNA^Phe^ to produce Tyr-tRNA^Phe^, which was then purified, and reactions were performed as described previously ([@gks1240-B17]). Reaction mixture contained 1 µM Tyr-tRNA^Phe^ and 100--500 nM wild-type or mutant PheRS. Bovine serum albumin was used as a negative control and 0.1 M NaOH as a positive control.

Steady-state kinetics
---------------------

Steady-state kinetic assays were carried out at 37°C as previously described ([@gks1240-B17],[@gks1240-B29]). For ATP-PP~i~ exchange assays, concentrations of substrates were varied from 0.5 to 200 µM for Phe, and 0.1 to 9 mM for Tyr. Enzymes were added to a final concentration of 100--150 nM. For steady-state aminoacylation assays, concentrations of substrates were varied from 0.5 to 100 µM for Phe, 20 to 400 µM for Tyr and 0.5 to 40 µM for tRNA^Phe^. For cognate and non-cognate charging reactions, final PheRS concentrations used were 100 and 500 nM, respectively. Kinetic parameters were determined as averages from three independent reactions, and their standard errors are shown.

Single-turnover kinetics
------------------------

Experiments were performed at 22°C on a quench flow RQF-3 KinTek instrument, using the constant quench option. The buffer for PheRS contained 100 mM Na-Hepes (pH 7.2), 30 mM KCl, 10 mM MgCl~2~ and 10 mM dithiothreitol (DTT), whereas the quench solution contained 3 M sodium acetate (pH 4.5). The PheRS-aminoacyl-AMP complex is not stable following purification, so the complex was formed *in situ* in the first syringe as described previously ([@gks1240-B31]). The sample was then mixed rapidly with tRNA^Phe^ in the second syringe and quenched at various time intervals. In syringe A, enzyme-aminoacyl-adenylate complex was formed *in situ* by incubating 6--8 µM PheRS, 40 µM \[^14^C\]-Phe (215 cpm/pmol) or 80 µM \[^14^C\]-Tyr (360 cpm/pmol), 4 mM ATP and 2 units/mL of inorganic pyrophosphatase. Syringe B contained 2--4 µM tRNA^Phe^. Reaction aliquots of 36 µl (18 µl in each syringe) were quenched and precipitated in 5% trichloroacetic acid. The radiolabeled aa-tRNA products were quantified by scintillation counting. Amount of aa-tRNA formed was plotted versus time and fitted to the single exponential equation, *y* = *C* + *A*\*\[1 − *exp*( − *k~trans~* × *t*)\], where *C* is the *y* intercept, *A* is the amplitude, *k~trans~* is the rate of aminoacyl transfer and *t* is time in seconds. Phe and Tyr transfer rate constants were determined by single-turnover kinetics using 6--8 µM PheRS and 3--4 µM *Mm*tRNA^Phe^ or *Ec*tRNA^Phe^. For *Ec*PheRS, the αA294G βG318W editing-defective variant was used to prevent significant hydrolysis of Tyr-tRNA^Phe^ during the assay. Data represent averages of three independent experiments and the corresponding standard errors.

*E. coli* NP37 *pheS*^ts^ complementation
-----------------------------------------

The *E. coli* NP37 strain \[*pheS*^ts^, ([@gks1240-B32])\] was co-transformed with plasmids pQE31-*Mm*PheRS (amp^r^) and pREP4 (kan^r^, Qiagen) to ensure tight transcriptional regulation of plasmid-encoded PheRS. The transformants were plated on Luria broth (LB) supplemented with 100 µg/ml ampicillin and 50 µg/ml kanamycin and incubated at 30°C. Individual colonies were then streaked and grown on the same media as aforementioned at both 30°C and 42°C for 24--48 h. To ensure the colonies appearing at 42°C were not revertants, the presence of the *pheS*^ts^ mutation in *E. coli* NP37 was confirmed by sequencing.

RESULTS
=======

*Mm*PheRS lacks canonical quality control activities
----------------------------------------------------

Previous analyses of components of the *M. mobile* proteome showed mistranslation of up to 0.7% of Phe codons, as Tyr and preliminary sequence analyses suggested this was, in part, because of PheRS-specific editing defects ([@gks1240-B28]). In *E. coli* PheRS (*Ec*PheRS), the highly conserved residues βR244, βH265, βG318, βE334, βT354 and βA356 are all involved in editing ([@gks1240-B33]). βR244, which interacts with the tRNA backbone primarily at C75, is replaced by Lys in most *Mycoplasma* species. Although *Mm*PheRS retains the well-conserved His residue in the signature motif QPx[H]{.ul}xFD, other key residues are not well conserved, including the second signature motif, GVMG[G]{.ul}xxS/T, which aligns poorly because of extensive sequence changes, possibly indicative of changes in the editing activity of the *M. mobile* enzyme ([Figure 1](#gks1240-F1){ref-type="fig"}). For the cognate amino acid Phe, some differences were observed between *Mm*PheRS and EcPheRS, with the *M. mobile* enzyme having a 2-fold higher *k*~cat~/*K*~M~ in ATP-PP~i~ exchange and the *E. coli* enzyme a 9-fold higher *k*~cat~/*K*~M~ for aminoacylation \[[Tables 1](#gks1240-T1){ref-type="table"} and [2](#gks1240-T2){ref-type="table"}; ([@gks1240-B35])\]. For non-cognate Tyr, *Mm*PheRS showed negligible post-transfer editing of Tyr-tRNA^Phe^ compared with either wild-type *Ec*PheRS or the αA294G βG318W variant, which has ∼80-fold reduced activity compared with wild-type \[[Figure 2](#gks1240-F2){ref-type="fig"}A; ([@gks1240-B33])\]. The absence of post-transfer editing rendered *Mm*PheRS considerably more error prone than its *E. coli* counterpart, as shown by its ability to synthesize and accumulate Tyr-tRNA^Phe^ ([Figure 2](#gks1240-F2){ref-type="fig"}B). The level of mischarging by *Mm*PheRS was comparable with that of the αA294G βG318W editing-deficient *E. coli* variant and is in contrast to WT *Ec*PheRS, which does not produce any detectable mischarged Tyr-tRNA^Phe^. These results indicate that *Mm*PheRS lacks post-transfer editing activity and is inherently error prone. Figure 1.Editing site sequence alignments for bacterial PheRSs. Sequences are from the first (top) and second (bottom) signature motifs using *E. coli* numbering. See main text for details. Inset is the structure of the *Thermus thermophilus* editing site in complex with Tyr, with *E. coli* numbering in parentheses ([@gks1240-B34]). Figure 2.Aminoacylation and editing activities of *Mm*PheRS. (**A**) Post-transfer editing of preformed Tyr-tRNA^Phe^ by *Mm*PheRS. WT *Ec*PheRS and 0.1 M NaOH serve as positive controls and editing-deficient αA294G βG318W *E. coli* PheRS as a negative control. (**B**) Tyrosylation of *Mm*tRNA^Phe^ by *Mm*PheRS, *Ec*PheRS and the αA294G βG318W *E. coli* PheRS editing-deficient mutant. Data represent averages of three independent experiments and the corresponding standard errors. Table 1.Steady-state kinetic constants for tRNA aminoacylation by *Mm*PheRSAmino acid*k*~cat~ (s^−1^)*K*~M~ (µM)*k*~cat~/*K*~M~ (s^−1^µM^−1^)Specificity (*k*~cat~/*K*~M~) Phe/(*k*~cat~/*K*~M~) TyrPhe0.10 ± 0.033.3 ± 0.50.040 ± 0.003Tyr0.0100 ± 0.0005130 ± 409 × 10^−5^ ± 0.3 × 10^−5^440 Table 2.Steady-state kinetic constants for ATP-\[^32^P\]PPi exchange by wild-type and *Mm*PheRS variantsPheTyr*Mm*PheRS*k*~cat~ (s^−1^)*K*~M~ (µM)*k*~cat~/*K*~M~ (s^−1^µM^−1^)*k*~cat~ (s^−1^)*K*~M~ (µM)*k*~cat~/*K*~M~ (s^−1^µM^−1^)Specificity[^a^](#gks1240-TF1){ref-type="table-fn"} (Phe/Tyr)WT10.0 ± 0.210 ± 11.0 ± 0.28.0 ± 0.43900 ± 5400.0021 ± 0.0003∼500(T305A24 ± 411 ± 12.3 ± 0.53.4 ± 0.82060 ± 400.0017 ± 0.0004∼1350βQ306A18 ± 310 ± 42.1 ± 0.65 ± 13850 ± 15900.0014 ± 0.0002∼1500(T305A/Q306A15 ± 49.0 ± 0.11.7 ± 0.4NDND0.0006 ± 0.000[^b^](#gks1240-TF2){ref-type="table-fn"}∼3000[^1][^2][^3]

In the absence of post-transfer editing activity, it is possible that *Mm*PheRS relies instead for quality control on highly stringent Phe recognition and Tyr discrimination. This mechanism is also used by yeast mitochondrial PheRS to compensate for its inability to edit Tyr-tRNA^Phe^ ([@gks1240-B27]). Steady-state kinetic analyses of *Mm*PheRS revealed a Phe:Tyr specificity ratio during aminoacylation of 440:1 ([Table 1](#gks1240-T1){ref-type="table"}). Examination of amino acid specificity during ATP-dependent activation indicated that the *Mm*PheRS active site displays specificity for Phe over Tyr of 480:1 ([Table 2](#gks1240-T2){ref-type="table"}). The specificity for Phe over Tyr of *MmPheRS* is 14-fold lower than that of *Ec*PheRS, demonstrating a substantial reduction in discrimination against the near-cognate amino acid.

Pre-transfer editing provides a potential additional quality control mechanism to prevent usage of near-cognate Tyr by PheRS. To investigate possible pre-transfer editing by *Mm*PheRS, ATP consumption assays were performed using either cognate Phe or near-cognate Tyr, in the presence or absence of tRNA^Phe^. The level of ATP consumption in the presence of Tyr was similar to that in the presence of Phe. ATP consumption increased on addition of tRNA in the presence of Tyr, but not Phe, suggesting weak tRNA-dependent editing activity ([Figure 3](#gks1240-F3){ref-type="fig"}A). To distinguish between *cis*-post-transfer editing and tRNA-dependent pre-transfer editing, we used a non-chargeable substrate, 2′-deoxy *Ec*tRNA^Phe^ ([@gks1240-B17]). In the presence of Tyr and 2′-deoxy *Ec*tRNA^Phe^, the ATP consumption rate was similar to that found in the presence of Tyr and chargeable tRNA ([Figure 3](#gks1240-F3){ref-type="fig"}B). These data indicate that *Mm*PheRS exhibits tRNA-dependent pre-transfer hydrolysis activity, which provides a modest, ∼2-fold, discrimination between Phe and Tyr ([Figure 3](#gks1240-F3){ref-type="fig"}A). The relatively low substrate specificity of amino acid activation, weak pre-transfer-editing and absence of post-transfer editing together show that *Mm*PheRS lacks all of the canonical quality control mechanisms normally used by aaRS enzymes to prevent non-cognate aa-tRNA synthesis. Figure 3.ATP hydrolysis by *Mm*PheRS. (**A**) ATP hydrolysis activity in the presence of cognate Phe (1 mM) or noncognate Tyr (5 mM), with or without *Mm*tRNA^Phe^ (10 µM). (**B**) tRNA-dependent ATP hydrolysis in the presence of non-cognate Tyr (5 mM) with *Mm*tRNA^Phe^ (5 µM), 2′-deoxy *Ec*tRNA^Phe^ (5 µM) or no tRNA. ATP hydrolysis was monitored in the absence of enzyme during each experiment and subtracted from data points. Data represent averages of three independent experiments and the corresponding standard errors.

Kinetic proofreading during amino acid transfer by *Mm*PheRS
------------------------------------------------------------

Steady-state amino acid activation rates (*k*~cat~) for *Mm*PheRS were similar with both Phe and Tyr, whereas the overall rate of tRNA charging with Tyr was ∼10-fold lower than that with Phe. This finding suggests *Mm*PheRS may kinetically discriminate against near-cognate Tyr at a step subsequent to activation, either aminoacyl transfer to tRNA or release of aminoacyl-tRNA. Previous studies showed that aminoacyl-tRNA release is not the rate-determining step during aminoacylation by *Ec*PheRS ([@gks1240-B36; @gks1240-B37; @gks1240-B38]), and this was also found to be the case for *Mm*PheRS ([Figure 4](#gks1240-F4){ref-type="fig"}). Using αA294G and αA294S *Ec*PheRS variants, which can accommodate unnatural Phe analogs such as *p-*chlorophenylalanine (*p*-Cl Phe), aminoacyl transfer rate constants were previously measured for cognate Phe and *p*-Cl Phe ([@gks1240-B38]). *p*-Cl Phe transferred to tRNA^Phe^ at a faster rate than Phe, indicating that near- or non-cognate aminoacyl-AMP intermediates form less stable complexes with *Ec*PheRS than their cognate counterparts. Using rapid quench assays under single-turnover conditions, *k*~trans~ was measured for Tyr and Phe. An *Ec*PheRS editing-deficient mutant (αA294G βG318W) was used to prevent hydrolysis of mischarged Tyr-tRNA^Phe^ during the timescale of the reaction. The observed *k*~trans~ for Tyr was ∼2-fold higher (30 ± 2 s^−1^) than that for Phe (16 ± 3 s^−1^), consistent with previous studies ([@gks1240-B38]). In contrast, for *Mm*PheRS, the rate of Phe transfer (16 ± 2 s^−1^) was 5-fold faster than the rate of Tyr transfer (3 ± 0.4 s^−1^). These data reveal that *Mm*PheRS, unlike its *E. coli* counterpart, uses a distinct mechanism to discriminate cognate from near-cognate substrates based on kinetic proofreading of aminoacyl-adenylates during the transfer step of the aminoacylation reaction. Figure 4.Transient kinetics of *Mm*PheRS. Time course of aminoacylation in pre-steady-state burst conditions (0.5 μM PheRS and 20 μM tRNA^Phe^). The absence of a burst of product formation indicates that product release is not rate limiting, in contrast to aaRSs where product release is rate limiting ([@gks1240-B31]).

Restoring canonical quality control in *Mm*PheRS
------------------------------------------------

*In vitro* studies (see earlier) showed that *Mm*PheRS lacks canonical quality control mechanisms and suggest that the enzyme may not be able to support growth of organisms, such as *E. coli*, where translation is predicted to be more accurate than in *M. mobile*. The *in vivo* activity of *Mm*PheRS in a comparatively accurate cellular context was investigated using the *E. coli* strain NP37, which contains a temperature-sensitive (*ts*) chromosomal *pheS* allele that restricts growth at 42°C. Wild-type *Ec*PheRS displayed robust complementation, while *Mm*PheRS was unable to rescue growth of *E. coli* NP37 at 42°C ([Figure 5](#gks1240-F5){ref-type="fig"}A). *E. coli* tRNA^Phe^ is highly homologous to *M. mobile* tRNA^Phe^, and both *Ec*PheRS and *Mm*PheRS can cross-aminoacylate either tRNA ([Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1240/-/DC1)), suggesting the lack of complementation by *Mm*PheRS does not result from a tRNA recognition defect. Cross-species tRNA recognition was further supported by the ability of PheRS *M. mobile* α-subunits and *E. coli* β-subunits produced together *in vivo* to rescue growth ([Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1240/-/DC1)). To investigate whether the absence of complementation *in vivo* stemmed from the relatively poor quality control observed *in vitro* with *Mm*PheRS, sequence alignment-based variants of *Mm*PheRS were constructed in an attempt to restore proofreading activity. Replacements were confined to the second editing motif of the β-subunit (G~315~VMGGxxS/T, *E. coli* numbering), which is considerably diverged in *M. mobile* when compared with the canonical, conserved, bacterial signature sequence ([Figure 1](#gks1240-F1){ref-type="fig"}). In the second editing motif of *Mm*PheRS, all three Gly residues have been replaced by relatively bulkier residues (βY302, βT305 and βQ306), which may occlude Tyr from the editing active site. The impact of these changes on the quality control activities of *Mm*PheRS was investigated by making Ala and Gly substitutions of βY302, βT305 and βQ306. βY302A/G, βT305A/G and βQ306A/G *Mm*PheRS-encoding genes were then screened for their *in vitro* activities and ability to rescue the *ts* phenotype of *E. coli* NP37 ([Table 3](#gks1240-T3){ref-type="table"}). Only genes encoding βT305A and βQ306A *Mm*PheRS rescued growth at 42°C, as did the βT305A/Q306A variant, albeit poorly ([Figure 5](#gks1240-F5){ref-type="fig"}A). Figure 5.Activity of *Mm*PheRS quality control variants**.** (**A**) Rescue of growth phenotype of *E. coli* NP37 (*pheS*^ts^). *E. coli* NP37 was transformed with plasmids producing WT *Mm*PheRS, *Mm*PheRS variants βT305A, βQ306A and βT305A/Q306A and WT *Ec*PheRS as positive and empty vector as negative controls, respectively. (**B**) Phenylalanylation and (**C**) tyrosylation by WT *Mm*PheRS and variants βT305A, βQ306A and βT305A/Q306A. Data represent averages of three independent experiments and the corresponding standard errors. Table 3.Properties of *Mm*PheRS quality control variants*Mm*PheRSPhe-tRNA^Phe^ (Relative)[^a^](#gks1240-TF4){ref-type="table-fn"}Tyr-tRNA^Phe^ (Relative)[^b^](#gks1240-TF5){ref-type="table-fn"}Viability[^c^](#gks1240-TF6){ref-type="table-fn"}WT11NoβP301G0.20.1NoβY302G12NoβT305G12.5NoβQ306G11NoβT305G/βQ306GND[^d^](#gks1240-TF7){ref-type="table-fn"}NDNoβY302G/βT305G/βQ306GNDNDNoβT305A10.4YesβQ306A10.4YesβT305A/βQ306A10.4Yes[^4][^5][^6][^7]

The ability of the sequence alignment-based *Mm*PheRS variants to synthesize Phe-tRNA^Phe^ and Tyr-tRNA^Phe^ was examined *in vitro*. βT305A, βQ306A and βT305A/Q306A *Mm*PheRS all showed normal levels of Phe-tRNA^Phe^ and reduced Tyr-tRNA^Phe^ synthesis compared with wild-type, indicative of elevated quality control and consistent with the complementation activities of the corresponding genes ([Table 3](#gks1240-T3){ref-type="table"}; [Figures 5](#gks1240-F5){ref-type="fig"}B and [5](#gks1240-F5){ref-type="fig"}C). *Trans*-editing assays showed that the Ala substitutions at T305A and Q306A had not restored post-transfer editing activity, nor did ATP consumption assays show an increased rate of AMP production, indicating that none of the three *Mm*PheRS variants had acquired editing function. Amino acid activation kinetics showed that the βT305A and βQ306A replacements all increased specificity for Phe over Tyr by 3- to 6- fold compared with wild-type, consistent with the observed reduction in Tyr-tRNA^Phe^ synthesis ([Table 2](#gks1240-T2){ref-type="table"}). These data indicate that the sequence alignment-based replacements in the second editing motif support *E. coli* growth by partially restoring a canonical quality control activity normally absent from *Mm*PheRS*.* Despite all the *Mm*PheRS variants being at residues in the defunct editing domain, increased quality control resulted from improved amino acid discrimination at the active site in the α-subunit rather than restoration of editing activity in the β-subunit. This suggests communication between the editing and synthetic active sites, analogous to the recent observation that fusion of a CP1 editing domain to *M. mobile* leucyl-tRNA synthetase (LeuRS) leads to enhancement of amino acid discrimination during the activation step in addition to conferring post-transfer editing activity ([@gks1240-B39]).

DISCUSSION
==========

Structural and functional divergence of PheRS
---------------------------------------------

The proteome of the obligate intracellular pathogen *M. mobile* contains significant amino acid ambiguities, with misincorporation rates at Leu and Phe codons estimated to be as high as 1 in 200 ([@gks1240-B28]). The absence of the canonical CP1 domain, and the accompanying loss of editing activity, in *M. mobile* LeuRS suggested that mistranslation of Leu codons resulted from elevated levels of mischarged tRNA^Leu^. Our data suggests that the same is true for mistranslation of Phe codons in *M. mobile*, which likely results from elevated levels of mischarged tRNA^Phe^. Detailed *in vitro* analyses showed that the relatively low accuracy of *Mm*PheRS aminoacylation results from changes at all steps in the reaction rather than loss of a single quality control step. Previous studies have shown that PheRS displays considerable divergence in quality control; some organisms, such as *E. coli,* retain multiple quality control steps while others, such as yeast, depend on single steps to maintain cellular viability ([@gks1240-B27],[@gks1240-B29]). In addition, even when only a single quality control mechanism is retained, as in both yeast PheRSs, this is still not essential for cellular viability ([@gks1240-B27]). These findings suggest that, under appropriate growth conditions, PheRS could evolve to dispense entirely with canonical quality control and still maintain cellular viability. This was confirmed by the *in vitro* and *in vivo* data presented here for *Mm*PheRS. In addition to losing canonical quality control pathways, *Mm*PheRS has acquired the ability to kinetically discriminate against non-cognate intermediates during the aminoacyl transfer step. Kinetic proofreading provides a mechanism to increase fidelity at lower time and energy costs compared with recycling reactions such as post-transfer editing ([@gks1240-B40],[@gks1240-B41]), but its capacity to maintain adequately fast and accurate aa-tRNA synthesis during translation has been questioned ([@gks1240-B14]). Analysis of *Mm*PheRS aminoacylation shows that kinetic proofreading alone can support viable translation, but only in cellular systems with relatively low requirements for translational accuracy.

The functional divergence of *Mm*PheRS may also have been facilitated by the expected effect on the proteome of the high AT content of *Mycoplasma* genomes ([@gks1240-B42],[@gks1240-B43]). Bioinformatic analyses have shown that organisms containing AT-rich genomes possess a greater bias to AT-rich codons encoding the amino acids Phe, Tyr, Met, Ile, Asn and Lys rather than GC-rich codons coding for Gly, Ala, Arg and Pro ([@gks1240-B44]). Comparison of the sequences of *Mm*PheRS and *Ec*PheRS shows a strong tendency toward the amino acid substitutions predicted from changes in nucleotide bias ([Figure 6](#gks1240-F6){ref-type="fig"}). This trend away from certain amino acids would be expected to favor substitutions at various key synthetic and editing site residues ([Figure 1](#gks1240-F1){ref-type="fig"}). Therefore, nucleotide bias appears to have acted as a non-specific factor facilitating a shift in the amino acid composition and functional properties of *Mm*PheRS. Figure 6.Amino acid composition of PheRS. Dark gray bars represent *Mm*PheRS and light gray bars represent *E. coli* PheRS.

Relaxation of aaRS quality control confines mistranslation to structurally related amino acid pairs
---------------------------------------------------------------------------------------------------

The *Mycoplasma* proteome contains a substantially higher level of ambiguous decoding than routinely observed in other bacteria such as *E. coli* ([@gks1240-B28]). Translational ambiguity can arise via different mechanisms. For instance, ribosomal ambiguity (ram) mutations cause miscoding by increasing the affinity of ribosomes for non-cognate aa-tRNA in a non-specific codon-independent manner ([@gks1240-B45]). Another general mechanism of mistranslation involves mismethionylation of several tRNA species by MetRS in bacteria, as well as mammalian cells, which is believed to protect against oxidative stress ([@gks1240-B24],[@gks1240-B25]). In contrast to these general mechanisms that lead to mistranslation, variability in the *M. mobile* proteome is confined to specific amino acid substitutions. In particular, decoding of Leu and Phe codons is highly erroneous with rates of ∼1 in 200 versus an error rate of ≤1 in 3000 for translation of other codons. Data presented here, together with recent studies on *Mm*LeuRS ([@gks1240-B25]), suggest that functional divergence of aaRSs allows for error modulation by restricting mistranslation to a subset of codons rather than causing a global defect. Reducing the stringency of the quality control steps used by *M. mobile* aaRSs targets translation errors to near-cognate amino acids, ensuring that any changes in the composition of the proteome following mistranslation are structurally and functionally conservative. While modulating aaRS-quality control has less impact on the overall integrity of the proteome than non-specific mistranslation, the selective advantage of reducing the accuracy of translation is unclear. One potential advantage, as proposed by Li *et al.* ([@gks1240-B28]), is that mistranslation may protect *M. mobile* from host defenses by increasing antigen diversity. This is analogous to some mechanisms proposed to promote the diversity of peptides presented by major histocompatibility complex molecules ([@gks1240-B46]). Our studies now show that modulating aaRS amino acid specificity may provide a potential mechanism to adapt to different stresses, and further studies of the divergence of quality control mechanisms may provide new insights into the physiology of the corresponding organisms.
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[^1]: ^a^Specificity (Phe/Tyr) = (*k*~cat~/*K*~M~)Phe/(*k*~cat~/*K*~M~)Tyr.

[^2]: ^b^*k*~cat~/*K*~M~ was estimated using sub-saturating Tyr concentrations from the slope of the equation, V = *k*~cat~ \[E\]\[S\]/*K*~M.~

[^3]: ND, not determined.

[^4]: ^a^Steady-state aminoacylation level after 12 min compared with WT.

[^5]: ^b^Steady-state aminoacylation level after 15 (Gly substitutions) or 30 min (Ala substitutions) compared to WT.

[^6]: ^c^Ability to rescue growth of *E. coli* NP37 at 42°C.

[^7]: ^d^ND, no detectable activity.
